Immunopathology of schistosomiasis: A cautionary tale of mice and men

Immunology Today

Volumn 21, Issue 1, 2000, Pages 29-35

  Fallon, Padraic G ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CYTOKINE; GAMMA INTERFERON; IMMUNOGLOBULIN E; INTERLEUKIN 2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; B LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOKINE RESPONSIVE ELEMENT; EOSINOPHILIA; EXPERIMENTAL MODEL; HELMINTH; HEPATOMEGALY; HUMAN; IMMUNOPATHOLOGY; LEISHMANIA MAJOR; MOUSE; NONHUMAN; PLACENTAL TRANSFER; PRIORITY JOURNAL; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS; T LYMPHOCYTE SUBPOPULATION; TH1 CELL; TH2 CELL; WORM EGG;

EID: 0034097903     PISSN: 01675699     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-5699(99)01551-0     Document Type: Note

References (54)

1. Abbas A.A.et al. Functional diversity of helper T lymphocytes. Nature. 383:1996;787-793.
2. Allen J.E., Maizels R.M. Th1-Th2: reliable paradigm or dangerous dogma? Immunol. Today. 18:1997;387-392.
3. Wynn T.A., Cheever A.W. Cytokine regulation of granuloma formation in schistosomiasis. Curr. Opin. Immunol. 7:1995;505-511.
4. Mosmann T.R., Coffman R.L. Th1-cell and Th2-cell - different patterns of lymphocyte secretion lead to different functional properties. Annu. Rev. Immunol. 7:1989;145-173.
5. Mosmann T.R., Sad S. The expanding universe of T-cell subsets: Th1, Th2 and more. Immunol. Today. 17:1996;138-146.
6. Pearce E.J.et al. Downregulation of Th1 cytokine production accompanies induction of Th2 responses by a helminth, Schistosoma mansoni. J. Exp. Med. 173:1991;159-166.
7. Grzych J-M.et al. Egg deposition is the major stimulus for the production of Th2 cytokines in murine schistosomiasis mansoni. J. Immunol. 146:1991;1322-1327.
8. +T cells in acute Schistosoma mansoni infection. Eur. J. Immunol. 28:1998;1408-1416.
9. Mathew R.C., Boros D.L. Anti-L3T4 antibody treatment suppresses hepatic granuloma formation and abrogates antigen-induced IL-2 production in Schistosoma mansoni infection. Infect. Immun. 54:1986;820-826.
10. + T cell responses during infection with the helminth Schistosoma mansoni. J. Immunol. 157:1996;3046-3053.
11. + T cell-mediated granulomatous pathology in schistosomiasis is downregulated by a B cell-dependent mechanism requiring Fc receptor signalling. J. Exp. Med. 187:1998;619-629.
12. + cells at the site of antigen deposition predicts the development of a T helper 2 cell response to Schistosoma mansoni eggs. J. Immunol. 155:1995;4844-4853.
13. Rumbley C.A.et al. Activated eosinophils are the major source of Th2-associated cytokines in the schistosome granuloma. J. Immunol. 162:1999;1003-1009.
14. Kulberg M.C.et al. T cell-derived IL-3 induces the production of IL-4 by non-B, non-T cells to amplify the Th2-cytokine response to a non-parasite antigen in Schistosoma mansoni-infected mice. J. Immunol. 156:1996;1482-1489.
15. + T-cell subsets. Proc. Natl. Acad. Sci. U. S. A. 91:1994;18-22.
16. King C.L.et al. Cell sensitization to helminthic infection develops in utero in humans. J. Immunol. 160:1998;3578-3584.
17. Williams M.E.et al. Leukocytes of patients with Schistosoma mansoni respond with a Th2 pattern of cytokine production to mitogen or egg antigens but with a Th0 pattern to worm antigens. J. Infect. Dis. 170:1994;946-954.
18. Araujo M.I.et al. Evidence for T helper type 2 activation in human schistosomiasis. Eur. J. Immunol. 26:1996;1399-1403.
19. Sabin E.A.et al. Impairment of tetanus toxoid-specific Th1-like immune responses in humans infected with Schistosoma mansoni. J. Infect. Dis. 173:1996;269-272.
20. Colley D.G.et al. Immune responses and immunoregulation in relation to human schistosomiasis in Egypt. III. Immunity and longitudinal studies of in vitro responsiveness after treatment. Trans. R. Soc. Trop. Med. Hyg. 80:1986;952-957.
21. King C.L.et al. Cytokine control of parasite-specific anergy in human urinary schistosomiasis-IL-10 modulates lymphocyte-reactivity. J. Immunol. 156:1996;4715-4721.
22. Cheever A.W. Quantitative comparison of the intensity of Schistosoma mansoni infections in man and experimental animals. Trans. R. Soc. Trop. Med. Hyg. 63:1969;781-795.
23. Kardorff R.et al. Lack of ultrasonographic evidence for severe hepatosplenic morbidity in Schistosomiasis mansoni in Mali. Am. J. Trop. Med. Hyg. 51:1994;190-197.
24. Henderson G.S.et al. Two distinct pathological syndromes in male CBA/J inbred mice with chronic Schistosoma mansoni infections. Am. J. Pathol. 142:1993;703-714.
25. Montesano M.A.et al. Immunoregulatory idiotypes stimulate T helper 1 cytokine responses in experimental Schistosoma mansoni infections. J. Immunol. 158:1997;3800-3804.
26. Montesano M.A.et al. Immune responses during human schistosomiasis mansoni. XVI. Idiotypic differences in antibody preparations from patients with different clinical forms of infection. J. Immunol. 142:1989;2501-2506.
27. Montesano M.A.et al. Neonatal idiotypic exposure alters subsequent cytokine, pathology, and survival in experimental Schistosoma mansoni infections. J. Exp. Med. 189:1999;637-645.
28. Eloi-Santos S.M.et al. Idiotypic sensitization in utero of children born to mothers with Schistosomiasis or Chagas disease. J. Clin. Invest. 84:1989;1028-1031.
29. Hernandez H.J.et al. Differential antigen recognition by T cell populations from strains of mice developing polar forms of granulomatous inflammation in response to eggs of Schistosoma mansoni. Eur. J . Immunol. 27:1997;666-670.
30. Salam E.A.et al. Association of HLA class I antigens (A1, B5, B8 and CW2)with disease manifestations and infection in human Schistosomiasis mansoni in Egypt. Tissue Antigens. 27:1986;142-146.
31. Secor W.E. et al. Association of hepatosplenic schistosomiasis with HLA-DQB1*0201. J. Infect Dis. 174:1996;1131-1135.
32. Fulford A.J.C. et al. Differences in the rate of hepatosplenomegaly due to Schistosoma mansoni infection between two areas in Machakos district, Kenya. Trans. R. Soc. Trop. Med. Hyg. 85:1991;481-488.
33. Doenhoff M.J. Granulomatous inflammation and the transmission of infection: schistosomiasis and TB too? Immunol. Today. 19:1998;462-467.
34. Karanja D.M.S.et al. Studies on Schistosomiasis in Western Kenya: I. Evidence for immune-facilitated excretion of schistosome eggs from patients with Schistosoma mansoni and human immunodeficiency virus coinfections. Am. J. Trop. Med. Hyg. 56:1997;515-521.
35. Wynn T.A.et al. Endogenous interleukin 12 (IL-12) regulates granuloma formation induced by eggs of Schistosoma mansoni and exogenous IL-12 both inhibits and prophylactically immunizes against egg pathology. J. Exp. Med. 179:1994;1551-1561.
36. Wynn T.A.et al. An IL-12-based vaccination method for preventing fibrosis induced by schistosome infection. Nature. 376:1995;594-596.
37. Estaquier J.et al. Interleukin-10-mediated T cell apoptosis during the T helper type 2 cytokine responses in murine Schistosoma mansoni parasite infection. Eur. Cytokine Netw. 8:1997;153-160.
38. Flores-Villanueva P.O.et al. Recombinant IL-10 and IL-10/Fc treatment down-regulate antigen-specific delayed hypersensitivity reactions and egg granuloma formation in schistosomiasis. J. Immunol. 156:1996;3315-3320.
39. Wynn T.A.et al. IL-10 regulates liver pathology in acute murine Schistosomiasis mansoni but is not required for immune down-modulation of chronic disease. J. Immunol. 160:1998;4473-4480.
40. Rosa Brunet L.et al. IL-4 protects against TNF-α mediated cachexia and death during acute schistosomiasis. J. Immunol. 159:1997;777-785.
41. Fallon P.G.et al. Schistosome infection of transgenic mice defines distinct and contrasting pathogenic roles for IL-4 and IL-13: IL-13 is a profibrotic agent. J. Immunol. 2000;. in press.
42. Fallon P.G., Dunne D.W. Tolerization of mice to Schistosoma mansoni egg antigens causes elevated type 1 and diminished type 2 cytokine responses and increased mortality in acute infection. J. Immunol. 162:1999;4122-4132.
43. Fallon P.G.et al. Elevated type 1, diminished type 2 cytokines and impaired antibody responses are associated with hepatotoxicity and mortalities during Schistosoma mansoni infection of CD4-depleted mice. Eur. J. Immunol. 2000;. in press.
44. Kaplan M.H.et al. Th2 cells are required for the Schistosoma mansoni egg-induced granulomatous response. J. Immunol. 160:1998;1850-1856.
45. McKenzie G.J.et al. Simultaneous disruption of interleukin (IL)-4 and IL-13 defines individual roles in T helper cell type 2-mediated responses. J. Exp. Med. 189:1999;1565-1572.
46. Rakasz E.et al. Localization and regulation of IFN-γ production within the granulomas of murine Schistosomiasis in IL-4 deficient and control mice. J. Immunol. 160:1998;4994-4999.
47. Zwingerberger K.et al. Tumour necrosis factor in hepatosplenic schistosomiasis. Scand. J. Immunol. 31:1990;205-211.
48. Mwatha J.K.et al. High levels of TNF, soluble TNF receptors, soluble ICAM-1, and IFN-γ, but low levels of IL-5, are associated with hepatosplenic disease in human schistosomiasis mansoni. J. Immunol. 160:1998;1992-1999.
49. Montenegro S.M.et al. Cytokine production in acute versus chronic human Schistosomiasis mansoni: the cross-regulatory role of interferon-gamma and interleukin-10 in the responses of peripheral blood mononuclear cells and splenocytes to parasite antigens. J. Infect. Dis. 179:1999;1502-1514.
50. Pearce E.J.et al. Schistosoma mansoni in IL-4 deficient mice. Int. Immunol. 8:1996;435-444.
51. Metwali A.et al. The granulomatous response in murine Schistosomiasis mansoni does not switch to Th1 in IL-4-deficient C57BL/6 mice. J. Immunol. 157:1996;4546-4553.
52. Hernandez H.J.et al. In infection with Schistosoma mansoni B cells are required for helper type 2 cell responses but not for granuloma formation. J. Immunol. 158:1997;4832-4837.
53. Murakami M.et al. Effects of breeding environments on generation and activation of ovreactive B-1 cells in anti-red blood cell autoantibody transgenic mice. J. Exp. Med. 185:1997;791-794.
54. Warren K.S. Correlation between experimental and human infection with Schistosoma mansoni. Nature. 201:1964;899-901.